Shipping to the 🇺🇸 starting at 60 USD, and FREE shipping on orders over 150 USD!

All orders are processed in MXN, using the latest exchange rates.

Shipping to 🇺🇸 within 4-10 business days.

Your cart

Your cart is empty

Desintoxicante natural para el cuerpo

Clinical Significance of Phase 2 Hepatic Biotransformation

Introduction

Hepatic biotransformation is a critical process that allows the body to convert lipophilic compounds, including environmental toxins, drugs, and other xenobiotics, into more water-soluble forms that facilitate their excretion. This process is divided into two main phases: phase 1, which introduces or exposes functional groups in the molecule, and phase 2, which involves the conjugation of these metabolites to form more soluble and, therefore, more easily excreted compounds.

Phase 2 of biotransformation is essential for the effective and safe detoxification of a wide range of exogenous and even endogenous substances. This phase is particularly relevant in the context of chronic exposure to environmental toxins, prolonged use of medications, chronic stress, and alcohol consumption, all of which can overload hepatic detoxification pathways and lead to the accumulation of toxic metabolites.

This article reviews in detail the metabolic pathways involved in phase 2 biotransformation, as well as the nutrients required to optimize this process, with a particular focus on N-acetylcysteine ​​(NAC), tauroursodeoxycholic acid (TUDCA), and coenzyme Q10 (CoQ10).

Metabolic Pathways of Phase 2 of Biotransformation

Phase 2 of biotransformation includes several conjugation pathways, each of which uses different cofactors and specific enzymes:

  1. Glutathione (GSH) conjugation: This pathway is catalyzed by the enzyme glutathione S-transferase (GST) and is crucial for the neutralization of electrophilic compounds, including reactive metabolites generated during phase 1, such as free radicals and quinone intermediates. Glutathione is a tripeptide composed of glutamine, cysteine, and glycine, with cysteine ​​being the rate-limiting amino acid for its synthesis.
  1. Sulfate Conjugation: Sulfonation is catalyzed by sulfotransferases (SULT) and is essential for the detoxification of phenols, alcohols, amines and steroid hormones. PAPS (3'-phosphoadenosine-5'-phosphosulfate) is the sulfate donor in these reactions, and its availability is dependent on cysteine ​​and methionine.
  1. Glucuronic Acid Conjugation: Glucuronidation is carried out by uridine 5'-diphosphate-glucuronosyltransferase (UGT) and is crucial for the detoxification of a wide range of compounds, including drugs, bilirubin and steroid hormones. This pathway facilitates the renal and biliary excretion of water-soluble compounds.
  1. Amino acid conjugation: Conjugation with amino acids, mainly glycine, glutamine and taurine, is used in the detoxification of organic acids. Glycine N-acyltransferase (GLYAT) is a key enzyme in this pathway, and its activity is essential for the neutralization of toxic metabolites derived from fatty acid metabolism.
  1. Methylation: Methylation reactions, mediated by methyltransferases, are crucial for the detoxification of amines, thiols, and phenols. S-adenosylmethionine (SAMe) acts as a methyl group donor, and the availability of methionine and folate is critical for maintaining adequate SAMe levels.

Impact of Xenobiotics in Phase 2 of Biotransformation

The liver is constantly exposed to a variety of xenobiotics that can overload detoxification pathways. Common ones include:

- Environmental Toxins: Exposure to heavy metals, pesticides and industrial pollutants.

- Medications: Chronic use of drugs such as paracetamol, anticonvulsants and antineoplastics.

- Chronic Stress: Prolonged stress induces the release of glucocorticoids, which can modify the expression of phase 2 enzymes, leading to inadequate detoxification.

- Alcohol consumption: Ethanol is metabolized to acetaldehyde, a highly toxic compound that requires conjugation with glutathione for detoxification. Excessive alcohol consumption depletes glutathione reserves, increasing the risk of hepatotoxicity.

Key Nutrients for Phase 2 Optimization

The efficiency of phase 2 of biotransformation depends largely on the availability of specific nutrients that act as cofactors or precursors in these metabolic pathways. Several B vitamins, magnesium, manganese, among others, are key to the normal development of biotransformation reactions. The following stand out due to their importance:

  1. N-acetylcysteine ​​(NAC): NAC is a direct precursor of cysteine, and therefore glutathione. Numerous studies have shown that NAC supplementation increases intracellular glutathione levels, improving the liver's ability to neutralize toxins and protect against oxidative damage. NAC is particularly useful in the treatment of acetaminophen toxicity and in the prevention of alcohol-induced hepatotoxicity.
  1. Tauroursodeoxycholic acid (TUDCA): TUDCA is a hydrophilic bile acid that improves mitochondrial function and protects against oxidative stress. TUDCA has been shown to promote the elimination of toxic bile acids and enhance the conjugation of lipophilic compounds, preventing xenobiotic-induced cholestasis.
  1. Coenzyme Q10 (CoQ10): CoQ10 is a fat-soluble antioxidant that plays a crucial role in the electron transport chain and in the regeneration of other antioxidants, such as glutathione. CoQ10 protects liver cells from xenobiotic-induced oxidative damage and improves mitochondrial function, which is essential for detoxification.

Conclusion

Phase 2 of hepatic biotransformation is a critical stage in xenobiotic detoxification, especially in the context of chronic exposure to environmental toxins, medications, stress, and alcohol consumption. Optimization of this phase depends on the availability of key nutrients such as N-acetylcysteine, TUDCA, and CoQ10, which not only support conjugation pathways but also protect against oxidative damage.

References

  1. Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother. 2003 May-Jun;57(3-4):145-55. doi: 10.1016/s0753-3322(03)00043-x. PMID: 12818476; PMCID: PMC6522248 .
  2. Gamage N, Barnett A, Hempel N, Duggleby RG, Windmill KF, Martin JL, McManus ME. Human sulfotransferases and their role in chemical metabolism. Toxicol Sci. 2006 Mar;90(1):5-22. doi: 10.1093/toxsci/kfj061. Epub 2005 Dec 1. PMID: 16322073.
  1. Radominska-Pandya A, Czernik PJ, Little JM, Battaglia E, Mackenzie PI. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev. 1999 Nov;31(4):817-99. doi: 10.1081/dmr-100101944. PMID: 10575553.
  1. Knights, K.M., Rowland, A., & Miners, J.O. (2013). Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT). British journal of clinical pharmacology , 76 (4), 587–602. https://doi.org/10.1111/bcp.12086 .
  1. Wagner C, Koury MJ. S-Adenosylhomocysteine: a better indicator of vascular disease than homocysteine? Am J Clin Nutr. 2007 Dec;86(6):1581-5. doi: 10.1093/ajcn/86.5.1581. PMID: 18065573. .
  1. Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016 Jan;16(1):22-34. doi: 10.1038/nri.2015.5. PMID: 26711676; PMCID: PMC5542678.
  2. Lieber CS. Metabolism of alcohol. Clin Liver Dis. 2005 Feb;9(1):1-35. doi: 10.1016/j.cld.2004.10.005. PMID: 15763227.
Previous post
Next post
Purchase options
Select a purchase option to pre order this product
Countdown header
Countdown message


DAYS
:
HRS
:
MINS
:
SECS